IP Library Granted Patent US 8,978,643
Granted Patent B2
US 8,978,643 · App. 13/501,700 · Granted Mar 17, 2015

Modification of sympathetic activation and/or respiratory function

Inventors: Steven Farrugia (Bella Vista, AU); Klaus Schindhelm (Bella Vista, AU)
Assignee: ResMed Limited
A61M16/00A61B5/0002A61B5/0816A61B5/087A61B5/145A61B5/4818A61M2205/18A61M2230/42
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,978,643
App. No.
13/501,700
Granted
Mar 17, 2015
Kind
B2
Abstract

Devices, systems and methods are disclosed for modifying sympathetic activation of a patient through alteration of respiratory function. In one form, a sub-apneic ventilation target for a ventilator is determined such that chronic sympathetic activation of the patient is mitigated.

Claims (88)

1. A method for determining a sub-apneic ventilation target for a ventilator comprising the steps of:

setting a ventilation target to an initial value;

monitoring a patient's respiration for a duration;

analyzing data representing the patient's respiration to detect events indicating an apneic threshold;

if no events are detected, increasing the ventilation target and continue to monitor the patient's respiration for a duration;

if events are detected, setting a sub-apneic threshold and reducing the ventilation target to substantially the sub-apneic threshold or lower to determine the sub-apneic ventilation target;

wherein the determined sub-apneic ventilation target is such that chronic sympathetic activation of the patient is mitigated when ventilation is provided at substantially the determined sub-apneic ventilation target.

2. A method of claim 1 , wherein the sub-apneic threshold is initially set at an initial value and is subsequently reset based on the detected events to an updated sub-apneaic threshold.

3. The method of claim 2 , wherein the updated sub-apneic threshold is used to treat the patient.

4. The method of claim 1 , wherein the determined sub-apneic ventilation target is used to treat the patient.

5. The method of claim 1 , wherein the determined sub-apneic ventilation target is less than the sub-apneic threshold by an additional margin and is use to treat the patient.

6. The method of claim 1 , wherein the ventilation is substantially maintained at the determined sub-apneic ventilation target.

7. The method of claim 1 , wherein the determined sub-apneic ventilation target is adjusted as needed over time to be substantially at the sub-apneic threshold or lower.

8. The method of claim 1 , wherein the sub-apneic threshold will vary over time and the chronic sympathetic activation of the patient is substantially continuously mitigated by increasing or decreasing the sub-apneic ventilation target as needed over time.

9. The method of claim 1 , wherein the method is computer implemented.

10. The method of claim 1 , wherein the events are detected using an apnea hypopnea index.

11. The method of claim 1 , wherein the events are detected when a hypopnea index is above a threshold.

12. The method of claim 1 , wherein the events are detected when an apnea index is above a threshold.

13. The method of claim 1 , wherein the events are detected when a patient's breath rate is below a threshold.

14. The method of claim 1 , wherein the events are detected when the ventilator mode switches to a timed mode.

15. The method of claim 1 , wherein the events are detected when an apnea hypopnea index is above a threshold a predetermined number of times.

16. The method of claim 1 , wherein the events are detected when a hypopnea index is above a threshold a predetermined number of times.

17. The method of claim 1 , wherein the events are detected when an apnea index is above a threshold a predetermined number of times.

18. The method of claim 1 , wherein the events are detected when the patient's breath rate is below a threshold a predetermined number of times.

19. A method of treating a patient for chronic sympathetic activation by setting a sub-apneic ventilation target of a ventilator in accordance with claim 1 .

20. The method of claim 19 , wherein the patient is asleep.

21. The method of claim 19 , wherein the patient is awake.

22. The method of claim 1 , wherein the ventilator is a bilevel ventilator.

23. A method of treating a patient for one or more of the conditions selected from the group consisting of hypertension, Type II diabetes, obesity, metabolic syndrome, and congestive heart failure, by setting a sub-apneic ventilation target of a ventilator in accordance with claim 1 .

24. The method of claim 1 , wherein the initial value for the ventilation target or the sub-apneic ventilation threshold is set to one or more values selected from the group consisting of a nominal physiological value, a value calculated using a formula; a value determined from a table; the patient's respiration value, and a stored value from a previous treatment session.

25. A processor-readable medium having instructions therein that, when executed, cause a processor to control a ventilator to treat a patient for chronic sympathetic activation by setting a sub-apneic ventilation target of the ventilator in accordance with the method of claim 1 .

26. The processor-readable medium of claim 25 , wherein the patient is asleep.

27. The processor-readable medium of claim 25 , wherein the patient is awake.

28. The processor-readable medium of claim 25 , wherein the ventilator is a bilevel ventilator.

29. A processor-readable medium having instructions therein that, when executed, cause a processor to control a ventilator to treat a patient for one or more of the conditions selected from the group consisting of hypertension, Type II diabetes, obesity, metabolic syndrome, and congestive heart failure, by setting a sub-apneic ventilation target of the ventilator in accordance with the method of claim 1 .

30. A device for treating a patient for chronic sympathetic activation by setting a sub-apneic ventilation target of a ventilator in accordance with the method of claim.

31. A device for treating a patient for one or more of the conditions selected from the group consisting of hypertension, Type II diabetes, obesity, metabolic syndrome, and congestive heart failure, by setting a sub-apneic ventilation target of a ventilator in accordance with the method of claim 1 .

32. The method of claim 1 , wherein the patient is not being treated for OSA.

33. The method of claim 1 , wherein the patient is also being treated for OSA.

34. The method of claim 1 , wherein the patient does not have OSA.

35. The method of claim 1 , wherein the patient does have OSA.

36. A processor-readable medium having instructions therein that, when executed, cause a processor to perform the steps of:

setting a ventilation target to an initial value;

monitoring a patient's respiration for a duration;

analyzing data representing the patient's respiration to detect events indicating an apneic threshold;

if no events are detected, increasing the ventilation target and continuing to monitor the patient's respiration;

if events are detected, setting a sub-apneic threshold and reducing the ventilation target to substantially the sub-apneic threshold or lower to determine a sub-apneic ventilation target;

wherein the sub-apneic ventilation target is such that chronic sympathetic activation of the patient is mitigated when ventilation is provided at substantially the sub-apneic ventilation target.

37. The processor-readable medium of claim 36 , wherein the events are detected when an apnea hypopnea index is above a threshold.

38. The processor-readable medium d of claim 36 , wherein the events are detected when a hypopnea index is above a threshold.

39. The processor-readable medium of claim 36 , wherein the events are detected when an apnea index is above a threshold.

40. The processor-readable medium of claim 36 , wherein the events are detected when the patient's breath rate is below a threshold.

41. The processor-readable medium of claim 36 , wherein the events are detected when an apnea hypopnea index is above a threshold a predetermined number of times.

42. The processor-readable medium of claim 36 , wherein the events are detected when a hypopnea index is above a threshold a predetermined number of times.

43. The processor-readable medium of claim 36 , wherein the events are detected when an apnea index is above a threshold a predetermined number of times.

44. The processor-readable medium of claim 36 , wherein the events are detected when a patient's breath rate is below a threshold a predetermined number of times.

45. The processor-readable medium of claim 36 , wherein the initial value is set to one or more values selected from the group consisting of a nominal physiological value, a value calculated using a formula; a value determined from a table; the patient's respiration value, and a stored value from a previous treatment session.

46. The processor-readable medium of claim 36 , wherein patient is not being treated for OSA.

47. The processor-readable medium of claim 36 , wherein the patient is also being treated for OSA.

48. The processor-readable medium of claim 36 , wherein the patient does not have OSA.

49. The processor-readable medium of claim 36 , wherein the patient does have OSA.

50. A device for determining a sub-apneic ventilation target for a ventilator comprising:

a blower in air communication with a mask worn by a patient;

a respiratory monitor;

a processor in communication with the respiratory monitor and the blower, wherein the processor controls the operation of the blower; and

a memory connected to the processor, wherein the memory has instructions therein that cause the processor to perform the steps of,

setting a ventilation target to an initial value;

monitoring the patient's respiration for a duration;

analyzing data representing the patient's respiration to detect events indicating an apneic threshold;

if no events are detected, increasing the ventilation target;

if events are detected, setting a sub-apneic threshold and reducing the ventilation target to substantially the sub-apneic threshold or lower to determine the sub-apneic ventilation target;

wherein the sub-apneic ventilation target is such that chronic sympathetic activation of the patient is mitigated when ventilation is provided at the sub-apneic ventilation target.

51. The device of claim 50 , wherein the events are detected when an apnea hypopnea index is above a threshold.

52. The device of claim 50 , wherein the events are detected when a hypopnea index is above a threshold.

53. The device of claim 50 , wherein the events are detected when an apnea index is above a threshold.

54. The device of claim 50 , wherein the events are detected when the patient's breath rate is below a threshold.

55. The device of claim 50 , wherein the events are detected when an apnea hypopnea index is above a threshold a predetermined number of times.

56. The device of claim 50 , wherein the events are detected when a hypopnea index is above a threshold a predetermined number of times.

57. The device of claim 50 , wherein the events are detected when an apnea index is above a threshold a predetermined number of times.

58. The device of claim 50 , wherein the events are detected when a patient's breath rate is below a threshold a predetermined number of times.

59. The device of claim 50 , wherein the patient is asleep.

60. The device of claim 50 , wherein the patient is awake.

61. The device of claim 50 , wherein the ventilator is a bilevel ventilator.

62. The device of claim 50 , wherein the initial value is set to one or more values selected from the group consisting of a nominal physiological value, a value calculated using a formula; a value determined from a table; the patient's respiration value, and a stored value from a previous treatment session.

63. The device of claim 50 , wherein the patient is not being treated for OSA.

64. The device of claim 50 , wherein the patient is also being treated for OSA.

65. The device of claim 50 , wherein the patient does not have OSA.

66. The device of claim 50 , wherein the patient does have OSA.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2015
From: FARRUGIA, STEVEN PAUL; SCHINDHELM, KLAUS HENRY
To: RESMED LIMITED
Reel/Frame 034910/0405 →
Continuity (2)
Provisional Application 61272628 · Oct 14, 2009
Related Publication 20120199126A1 · Aug 9, 2012